Wednesday 24 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Eden Research boasts that the taxpayer is funding promotion of its fraud

By Tom Winnifrith | Thursday 11 May 2017

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

AIM Cesspit listed FRAUD Eden Research (EDEN) has two massive problems. One is that with pitiful sales it is rapidly running out of cash and so must get yet another bailout placing away. The second is that it has now been fully exposed as committing a massive panama pump securities fraud HERE. Its response....

The company has issued the following release: 

Eden Research plc, the AIM-listed company that provides breakthrough natural bio-control products and microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, announces that yesterday's You & Yours, BBC Radio 4's consumer affairs programme, featured Eden Research plc's Mevalone, which used for the prevention and treatment of botrytis in table and wine grapes in a section of the programme labelled: The British innovation that's rejuvenating the French wine industry. 

Shareholders can listen to the section from 23.45 until 30.14 here: 

Eden received approval for sale of Mevalone in France in January this year following extensive consideration by the French Authorities and Regulatory Agencies. 


This is a 100% rehash of the bogus story Eden's reviled PR fucktards at Walbrook PR planted with a hapless journalist in the Sunday Times a few months ago. It was cobblers then, it is cobblers now. And it does not address the real issues: the fraud and the cash crisis.

Net current assets at June 30 2016 were £1.6 million. Cashburn is c £100,000 pcm. So net current assets right now are in the region of £600,000. Last year results came out on May 24. So calendar 2017 results must be imminent and unless there is a placing there is no way on earth that the auditors cannot pass comment on the question of whether this company - which has sent c £35 million to money heaven (more if you adjust for the accounting frauds) since its launch more than two decades ago, can continue as a going concern for the next 12 months.

In light of this, I am delighted that my taxes go to fund such high quality journalism at the loathsome state-funded BBC. The shares are down by 5% today at 11p to sell. It seems that fooling airhead journalists at the BBC is simpler than fooling investors. The stance is sell, target price 0p.

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on EDEN


Comments are turned off for this article.

Site by Everywhen